Arcellx, Inc. (ACLX)
68.94
+0.62
(+0.91%)
USD |
NASDAQ |
Jan 16, 16:00
68.93
-0.01
(-0.01%)
After-Hours: 20:00
Arcellx Shareholders Equity (Annual): 454.79M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Gilead Sciences, Inc. | 19.33B |
| Johnson & Johnson | 71.49B |
| Amicus Therapeutics, Inc. | 194.04M |
| Relmada Therapeutics, Inc. | 35.52M |
| Invivyd, Inc. | 67.54M |